Evidence map›Paper›PMID 41816007›Full record

ArticleBioinformatics advances2026

Advancing understanding of long COVID pathophysiology through quantum walk-based network analysis.

Jaesub Park, Woochang Hwang, Seokjun Lee, Hyun Chang Lee, Méabh MacMahon, Matthias Zilbauer, Namshik Han

Abstract read
In one paragraph

Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jaesub ParkCambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0AW, United Kingdom.ORCID https://orcid.org/0000-0002-4905-5980
Woochang HwangCardiaTec Biosciences Ltd, Cambridge, CB2 1GE, United Kingdom.ORCID https://orcid.org/0000-0003-0876-7305
Seokjun LeeCambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0AW, United Kingdom.
Hyun Chang LeeCambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0AW, United Kingdom.
Méabh MacMahonCardiaTec Biosciences Ltd, Cambridge, CB2 1GE, United Kingdom.
Matthias ZilbauerCambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0AW, United Kingdom.ORCID https://orcid.org/0000-0002-7272-0547
Namshik HanCambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0AW, United Kingdom.ORCID https://orcid.org/0000-0002-7741-6384

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Long COVID is a multisystem condition characterized by persistent symptoms such as fatigue, cognitive impairment, and systemic inflammation following COVID-19 infection. However, its mechanisms remain poorly understood. In this study, we applied the quantum walk, a computational approach leveraging quantum interference, to explore large-scale SARS-CoV-2-induced protein networks. Result: Compared to the conventional random walk with restart method, the quantum walk demonstrated superior capacity to traverse deeper regions of the network, uncovering proteins and pathways implicated in Long COVID. Key findings include mitochondrial dysfunction, thromboinflammatory responses, and neuronal inflammation as central mechanisms. Quantum walk uniquely identified the CDGSH iron-sulfur domain-containing protein family and VDAC1, a mitochondrial calcium transporter, as critical regulators of these processes. VDAC1 emerged as a potential biomarker and therapeutic target, supported by FDA-approved compounds such as cannabidiol. These findings highlight quantum walk as a powerful tool for elucidating complex biological systems and identifying novel therapeutic targets for conditions like Long COVID. Availability and implementation: The code and input data that were used for this study are available at https://github.com/Namshik-Han-Lab/QuantumWalk-LongCovid.

Identifiers

PMID41816007
PMCPMC12975004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.